Literature DB >> 11785697

In situ study of insulin aggregation induced by water-organic solvent interface.

Y M Kwon1, M Baudys, K Knutson, S W Kim.   

Abstract

PURPOSE: The aim of this study was to assess insulin stability by monitoring in situ time-course of insulin aggregation induced by a water-organic solvent (o/w) interface that occurs during the microencapsulation process.
METHODS: Insulin aggregation at a simple o/w interface was monitored spectrophotometrically by detecting the percentage of turbidity changes (%T) at 350 nm. The effects of protein concentration and agitation and the presence of poly (lactic-co-glycolic acid) (PLGA) in methylene chloride (MC) on insulin aggregation were observed. For the 0.72 mg/ml insulin in phosphate-buffered saline (PBS), the effect of nonionic (dodecyl maltoside [DDM]) and anionic (sodium dodecyl sulfate [SDS]) surfactant in PBS were also evaluated at various protein/surfactant mol ratios. The conformation of insulin protected by a 10-fold molar excess of SDS recovered after 1 h of contact with MC was evaluated via circular dichroism (CD) spectroscopy.
RESULTS: A typical turbidity-time profile was represented by a sigmoidal curve. Greater change in %T was observed with increasing insulin concentration, in the presence of PLGA in MC and in the presence of agitation. DDM failed to delay insulin aggregation at all ratios used, whereas a less than 10% change in %T was observed in 1 h when a 10- - approximately 20-fold excess of SDS was used. CD spectra indicated that the presence of insulin in SDS after 1 h of contact with MC qualitatively retained its secondary structure integrity.
CONCLUSIONS: An experimental method was designed for an in situ assessment of protein stability at the o/w interface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11785697     DOI: 10.1023/a:1013334916162

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-10-13       Impact factor: 15.470

2.  One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-10-13       Impact factor: 15.470

3.  Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces.

Authors:  V Sluzky; J A Tamada; A M Klibanov; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 4.  Toward understanding insulin fibrillation.

Authors:  J Brange; L Andersen; E D Laursen; G Meyn; E Rasmussen
Journal:  J Pharm Sci       Date:  1997-05       Impact factor: 3.534

5.  Stable insulin preparation for implanted insulin pumps. Laboratory and animal trials.

Authors:  U Grau; C D Saudek
Journal:  Diabetes       Date:  1987-12       Impact factor: 9.461

6.  Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

Authors:  J M Péan; F Boury; M C Venier-Julienne; P Menei; J E Proust; J P Benoit
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

7.  The binding of deoxycholate, Triton X-100, sodium dodecyl sulfate, and phosphatidylcholine vesicles to cytochrome b5.

Authors:  N C Robinson; C Tanford
Journal:  Biochemistry       Date:  1975-01-28       Impact factor: 3.162

8.  Stabilisation of dissolved proteins against denaturation at hydrophobic interfaces.

Authors:  H Thurow; K Geisen
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

9.  Mechanism of insulin aggregation and stabilization in agitated aqueous solutions.

Authors:  V Sluzky; A M Klibanov; R Langer
Journal:  Biotechnol Bioeng       Date:  1992-10-20       Impact factor: 4.530

10.  Physical stability of insulin formulations.

Authors:  W D Lougheed; A M Albisser; H M Martindale; J C Chow; J R Clement
Journal:  Diabetes       Date:  1983-05       Impact factor: 9.461

View more
  7 in total

1.  Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin at aqueous/organic interface.

Authors:  Ajay Taluja; You Han Bae
Journal:  Mol Pharm       Date:  2007-04-18       Impact factor: 4.939

2.  Hydrophilic microspheres from water-in-oil emulsions by the water diffusion technique.

Authors:  Michele Trotta; Daniela Chirio; Roberta Cavalli; Elena Peira
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

3.  Structure of human insulin monomer in water/acetonitrile solution.

Authors:  Wojciech Bocian; Jerzy Sitkowski; Elzbieta Bednarek; Anna Tarnowska; Robert Kawecki; Lech Kozerski
Journal:  J Biomol NMR       Date:  2007-11-27       Impact factor: 2.835

4.  Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.

Authors:  Young Min Kwon; Sung Wan Kim
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

5.  Metal-Organic Framework Encapsulation Preserves the Bioactivity of Protein Therapeutics.

Authors:  Congzhou Wang; Gail Sudlow; Zheyu Wang; Sisi Cao; Qisheng Jiang; Alicia Neiner; Jeremiah J Morrissey; Evan D Kharasch; Samuel Achilefu; Srikanth Singamaneni
Journal:  Adv Healthc Mater       Date:  2018-10-19       Impact factor: 9.933

6.  The stability of insulin solutions in syringes is improved by ensuring lower molecular weight silicone lubricants are absent.

Authors:  Lamees Nayef; Madiha F Khan; Michael A Brook
Journal:  Heliyon       Date:  2017-03-20

Review 7.  Interfacial tension effects on the properties of PLGA microparticles.

Authors:  Andrew Otte; Farrokh Sharifi; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2020-08-23       Impact factor: 5.999

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.